Sarcoma  >>  evofosfamide (IMGS-101)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
evofosfamide (IMGS-101) / Molecular Templates, ImmunoGenesis
EMR200592-008, NCT02255110: A Japanese Trial of TH-302 in Subjects With Locally Advanced Unresectable or Metastatic Soft Tissue Sarcoma

Terminated
2
6
Japan
TH-302, Doxorubicin
Merck KGaA, Darmstadt, Germany, Threshold Pharmaceuticals
Soft Tissue Sarcoma
01/16
01/16
NCT00742963: Dose-Escalation Study of TH-302 in Combination With Doxorubicin to Treat Patients With Advanced Soft Tissue Sarcoma

Completed
1/2
107
US
TH-302
Threshold Pharmaceuticals
Soft Tissue Sarcoma
07/13
10/13

Download Options